Drug Type Therapeutic vaccine |
Synonyms Mimotope P10s-PADRE/MONTANIDE ISA 51 VG vaccine(University of Arkansas), P10s-PADRE/ MONTANIDE ISA 51 VG(University of Arkansas) |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasm Metastasis | Phase 2 | - | 01 Mar 2021 | |
Solid tumor | Phase 2 | - | 01 Mar 2021 | |
Triple Negative Breast Cancer | Phase 2 | United States | 25 Jan 2019 | |
Advanced Lung Adenocarcinoma | Phase 2 | United States | 01 Oct 2015 | |
Metastatic Lung Cancer | Phase 2 | United States | 01 Oct 2015 | |
Metastatic breast cancer | Phase 1 | United States | 01 Jul 2011 |
Phase 1/2 | 16 | yzasgegpgr(bafyyxjxwu) = yjaknvzvol rinbcdrpfl (bgagdxeqsb, wvmffwsczq - istondlcmf) View more | - | 05 Jul 2024 | |||
Phase 1 | 6 | (Initial Cohort) | munfkolqwp = cyrdirkahd dicbvbkvue (dwkxsjlegm, rctqebsflv - uljixxfstm) View more | - | 03 Jun 2019 | ||
(Escalation Cohort) | munfkolqwp = dsocwltjql dicbvbkvue (dwkxsjlegm, qibgzlordi - ycrtfjnxaf) View more |